Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J B Malick

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Life Sciences|June 25, 1984
Neurochemical characteristics of rats distinguished as benzodiazepine responders and non-responders in a new conflict testJ B Patel, J Stengel, J B Malick, et al.
Neuropharmacology|December 1, 1983
Novel non-benzodiazepine anxiolyticsM E Goldberg, A I Salama, J B Patel, et al.
Life Sciences|March 16, 1987
D-2 dopamine antagonist-like effects of SCH 23390 on A9 and A10 dopamine neuronsJ M Goldstein, L C Litwin, E B Sutton, et al.
Psychopharmacology|January 1, 1993
Seroquel: electrophysiological profile of a potential atypical antipsychoticJ M Goldstein, L C Litwin, E B Sutton, et al.
Pharmacology, Biochemistry, and Behavior|October 1, 1985
Pharmacology of pyrazolopyridinesJ B Patel, J B Malick, A I Salama, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1989
Effects of ICI 169,369, a selective serotonin2 antagonist, in electrophysiological tests predictive of antipsychotic activityJ M Goldstein, L C Litwin, E B Sutton, et al.
Clinical Therapeutics|May 1, 1995
ICI 204,636, a novel, atypical antipsychotic: early indication of safety and efficacy in patients with chronic and subchronic schizophreniaL F Fabre, L Arvanitis, J Pultz, et al.
Neurobiology of Aging|January 1, 1981
Benzodiazepine receptor binding in young, mature and senescent rat brain and kidneyN W Pedigo, H Schoemaker, M Morelli, et al.
Pharmacology, Biochemistry, and Behavior|April 1, 1988
Preclinical studies with pyrazolopyridine non-benzodiazepine anxiolytics: ICI 190,622J B Patel, B A Meiners, A I Salama, et al.
Progress in Clinical and Biological Research|January 1, 1990
A novel potent non-benzodiazepine anxioselective agent with reduced dependence liability: ICI 198, 256J B Patel, B A Meiners, A I Salama, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Life Sciences|June 25, 1984
Neurochemical characteristics of rats distinguished as benzodiazepine responders and non-responders in a new conflict testJ B Patel, J Stengel, J B Malick, et al.
Neuropharmacology|December 1, 1983
Novel non-benzodiazepine anxiolyticsM E Goldberg, A I Salama, J B Patel, et al.
Life Sciences|March 16, 1987
D-2 dopamine antagonist-like effects of SCH 23390 on A9 and A10 dopamine neuronsJ M Goldstein, L C Litwin, E B Sutton, et al.
Psychopharmacology|January 1, 1993
Seroquel: electrophysiological profile of a potential atypical antipsychoticJ M Goldstein, L C Litwin, E B Sutton, et al.
Pharmacology, Biochemistry, and Behavior|October 1, 1985
Pharmacology of pyrazolopyridinesJ B Patel, J B Malick, A I Salama, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1989
Effects of ICI 169,369, a selective serotonin2 antagonist, in electrophysiological tests predictive of antipsychotic activityJ M Goldstein, L C Litwin, E B Sutton, et al.
Clinical Therapeutics|May 1, 1995
ICI 204,636, a novel, atypical antipsychotic: early indication of safety and efficacy in patients with chronic and subchronic schizophreniaL F Fabre, L Arvanitis, J Pultz, et al.
Neurobiology of Aging|January 1, 1981
Benzodiazepine receptor binding in young, mature and senescent rat brain and kidneyN W Pedigo, H Schoemaker, M Morelli, et al.
Pharmacology, Biochemistry, and Behavior|April 1, 1988
Preclinical studies with pyrazolopyridine non-benzodiazepine anxiolytics: ICI 190,622J B Patel, B A Meiners, A I Salama, et al.
Progress in Clinical and Biological Research|January 1, 1990
A novel potent non-benzodiazepine anxioselective agent with reduced dependence liability: ICI 198, 256J B Patel, B A Meiners, A I Salama, et al.
Pageof 3